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Exaptations are adaptive traits that do not originate de novo but from other adaptive traits. They 25 
include complex macroscopic traits, such as the middle ear bones of mammals, which originated 26 
from reptile jaw bones, but also molecular traits, such as new binding sites of transcriptional 27 
regulators. What determines whether a trait originates de novo or as an exaptation is unknown. I 28 
here use simple information theoretic concepts to quantify a molecular phenotype’s potential to 29 
give rise to new phenotypes. These quantities rely on the amount of genetic information needed 30 
to encode a phenotype. I use these quantities to estimate the propensity of new transcription 31 
factor binding phenotypes to emerge de novo or exaptively, and do so for 187 mouse 32 
transcription factors. I also use them to quantify whether an organism’s viability in one of 10 33 
different chemical environment is likely to arise exaptively. I show that informationally 34 
expensive traits are more likely to originate exaptively. Exaptive evolution is only sometimes 35 
favored for new transcription factor binding, but it is always favored for the informationally 36 
complex metabolic phenotypes I consider. As our ability to genotype evolving populations 37 
increases, so will our ability to understand how phenotypes of ever-increasing informational 38 
complexity originate in evolution. 39 






Evolution creates many traits from previously existing traits rather than de novo. This notion is 42 
as old as Charles Darwin’s Origin of Species, where Darwin pointed to examples that include the 43 
lungs of vertebrates, which are homologous to the swim bladders of fish, and respiratory organs 44 
of some barnacles, which he thought evolved from egg-retaining structures he called ovigerous 45 
frenae (Darwin, 1872, p 176-177). Multiple morphological examples like these were already 46 
known in the 19th century, and during the 20th century, numerous molecular examples were also 47 
discovered. They include the crystallins, proteins that allow eye lenses to refract light.  Many of 48 
them are co-opted from proteins that include metabolic enzymes and heat shock proteins 49 
(Piatigorsky and Wistow, 1989; Piatigorsky, 1998). Other examples include the regulatory 50 
circuits formed by Hox genes, which pattern the main body axis in many organisms and have 51 
been co-opted for multiple other purposes, among them vertebrate limb development (True and 52 
Carroll, 2002). Since the late 20th century such co-opted traits have been called exaptations 53 
(Gould and Vrba, 1982).  54 
Not all exaptations are created equal. Some exaptations require substantial change of an ancestral 55 
trait, like the change that transform a forelimb into a bat’s wing. Others, like crystallins, require 56 
as little change as expressing a gene in a new location like the eye lens. Yet others may require 57 
no genetic change at all.  Examples include enzymes that catalyze not just one main reaction but 58 
multiple side reactions – such as antibiotic resistance proteins that cleave one ‘native’ antibiotic 59 
and multiple others (Khersonsky and Tawfik, 2010). Such latent beneficial traits only require the 60 
right (antibiotic containing) environment to become adaptive, illustrating that environmental 61 
change can play an important role in the origin of exaptations.  62 
Many co-opted traits are bifunctional, serving their old and a new role simultaneously. For 63 
example, the fore- and hind-limbs of flying squirrels (Pteromyini) have been altered to help 64 
support the patagium, the membrane that allows these animals to glide between trees. At the 65 
same time, these limbs still allow walking and running (Thorington and Santana, 2007). Some 66 
such bifunctional intermediates undergo further refinement or secondary adaptation (Gould and 67 
Vrba, 1982).  Take feathers, which probably originated to keep a body warm (Norell and Xu, 68 
2005). Their shape and structure needed to be transformed before birds could fly, such that 69 
modern pennaceous feathers serve their new role in flight better than their original role in 70 
thermal insulation. In yet other traits, secondary adaptation causes a complete loss of the original 71 
role. A molecular example is the lactalbumin protein, which helps mammals synthesize lactose. 72 
It derives from lysozyme, an ancient enzyme, but has completely lost its original bacteriocidal 73 
function (Qasba and Kumar, 1997).  Another example involves the middle ear bones that 74 





which is derived from the quadrate bone of the reptilian upper jaw. In therapsids – extinct 76 
reptiles that include the ancestors of today’s mammals – the quadrate functioned both as part of 77 
the jaw joint and as part of the auditory system, but has since lost its original function in the jaw 78 
joint (Fay et al., 2004; Luo, 2007).  Most exaptations will have such bifunctional intermediates, 79 
because the simultaneous loss of an old phenotype and gain of a new phenotype is more difficult 80 
and rare than a gradual shift between phenotypes. I will thus focus on the transition between a 81 
trait and a bifunctional intermediate.  82 
The importance of exaptations in biological evolution has been defended largely on the basis of 83 
known examples. However, it would be useful to quantify how likely any one trait is to originate 84 
de novo or as an exaptation from another trait. And it would be useful to compare traits in this 85 
regard. Is it harder to evolve the Panda’s thumb from a sesamoid bone, or our inner ear bones 86 
from a reptilian jaw? Questions like this cannot currently be answered for morphological traits, 87 
because their genetic basis is too complex, involving hundreds of genes with poorly understood 88 
interactions. However, the answer may be within reach for simpler, molecular phenotypes whose 89 
genetic basis is better understood, and that can originate even on the short time scales of 90 
laboratory evolution. Examples include a cell’s ability to thrive in novel chemical environments, 91 
or to regulate genes in new ways (Blount et al., 2008; Dhar et al., 2011; Dhar et al., 2013; de 92 
Visser and Krug, 2014; Palmer et al., 2015; Toll-Riera et al., 2016).  93 
Building on previous work (Wagner, 2017), I here suggest a method to quantify a phenotype’s 94 
likelihood to evolve de novo. I apply the method to two simple kinds of molecular phenotype. 95 
The first of them is the ability of transcription factors to bind short DNA sequences, which is 96 
essential for gene regulation. The evolution of new transcription factor binding sites helps bring 97 
forth novel traits as different as new color phenotypes (Gompel et al., 2005) and novel body 98 
structures (Prud'homme et al., 2007; Guerreiro et al., 2013).  99 
The ability of a DNA sequence to bind a transcription factor is one of the simplest molecular 100 
phenotypes. It may evolve de novo or exaptively, from a binding site for a different transcription 101 
factor. For example, during the evolution of vertebrate αA-crystallin from a small heat shock 102 
protein, a transcription factor binding site known as a heat shock element was transformed into a 103 
binding site for the transcription factor Pax6, which helps drive crystalline expression in the eye 104 
lens (Cvekl et al., 2017). In the evolution of various cancers, mutations transform binding sites 105 
for the CCAAT-enhancer-binding protein (CEBP) into binding sites for multiple other 106 
transcription factors (Melton et al., 2015). Examples like these constitute the perhaps simplest 107 
possible molecular exaptations. Below I quantify from experimental DNA binding data how 108 
likely de novo or exaptive origins of new binding phenotypes are for 187 mouse transcription 109 





The second kind of novel phenotypes I study are metabolic phenotypes. More specifically, I 111 
study a metabolism’s ability to sustain life – to synthesize all essential biomass molecules – in 112 
chemical environments that contain a novel source of carbon and energy. This ability comes 113 
about through changes in the metabolic genotype that specifies which enzyme-catalyzed 114 
reactions can take place in a metabolism. I take advantage of powerful and experimentally 115 
validated computational methods to predict metabolic phenotypes from genotypes (Edwards et 116 
al., 2001; Segre et al., 2002; Papp et al., 2004; Price et al., 2004; Feist et al., 2007). With these 117 
methods, I study whether metabolic phenotypes are more likely to originate de novo or 118 
exaptively. More generally, I show how information theory can help quantify the potential of a 119 
trait to originate de novo or exaptively. And I show that this potential strongly depends on the 120 
kind of trait considered.  121 
Methods 122 
Transcription factor binding data. I analyze a genotype space of 48 DNA molecules of length 123 
eight nucleotides and within this space those molecules bound by at least one of 187 mouse 124 
transcription factors. I use binding data from the UniPROBE  (Newburger and Bulyk, 2009)(104 125 
transcription factors) and the CIS-BP databases (Weirauch et al., 2014) (83 transcription factors) 126 
data bases. This data is based on high-throughput DNA binding experiments reported in (Badis 127 
et al., 2009) and (Weirauch et al., 2014), and was previously used in an analysis of DNA binding 128 
landscapes (Aguilar-Rodriguez et al., 2017). The data set includes a transcription factor if (i) its 129 
binding has been measured on two different kinds of protein binding micro arrays, and if (ii) it 130 
binds a sufficient number of sequences to permit an analysis of nucleotide interactions in 131 
binding. In addition, each factor to be included must bind at least one sequence with an E-score 132 
exceeding 0.45 (Aguilar-Rodriguez et al., 2017). The E-score is a proxy for a factor’s relative 133 
binding affinity to a site. It is related to the Wilcoxon Mann Whitney test statistic, and ranges 134 
between -0.5 and +0.5 (strongest binding) (Badis et al., 2009). Because binding sites with 135 
E>0.35 are associated with a low false discovery rate of transcription factor binding 136 
(FDR=0.001), I here consider a site bound by any one factor if its E-score exceeds 0.35. I 137 
consider a non-palindromic binding site and its reverse complement as distinct sites.   138 
Metabolic network analysis. My analysis begins with a small “universe” of 51 possible 139 
biochemical reactions from E.coli central carbon metabolism (Figure S1), and with ten different 140 
chemically minimal environments that differ only in the sole carbon and energy source they 141 
contain. While six of the 51 reactions are essential for the operation of central carbon 142 
metabolisms in all these environments, the presence of the remaining 45 reactions can vary 143 
without affecting viability in at least some environments (Hosseini et al., 2015). I focus on these 144 





reaction networks that are formed by all possible subsets of the 45 variable reactions (Hosseini et 146 
al., 2015). I define viability as the ability to synthesize those 13 biomass precursors (Figure S1) 147 
that are the starting points for the biosyntheses of some 60 biomass molecules that are essential 148 
to free-living microbes like E.coli, including 20 amino acids and four DNA nucleotide building 149 
blocks (Stryer, 1995; Noor et al., 2010). The carbon sources that distinguish the ten minimal 150 
environments are acetate, 𝛼𝛼-ketoglutarate, fumarate, fructose, glucose, glutamate, lactate, malate, 151 
pyruvate, and succinate(Hosseini et al., 2015). I note that a metabolism viable on any one carbon 152 
source may be viable on other carbon sources as well (Barve and Wagner, 2013; Hosseini and 153 
Wagner, 2016).  154 
 155 
Concepts.  156 
My approach focuses on the amount of genetic information that a genotype needs to harbor in 157 
order to specify or “encode” a phenotype, in the sense that the expression of this information 158 
produces the phenotype. All phenotypic traits are encoded by genotypes in some genotype space 159 
(Figure 1a). I will denote the size of this space by the number of genotypes |G| in it. If every 160 
phenotype was specified by a single genotype, it would be trivial to quantify the amount of 161 
information needed to encode it. However, this is not the case. First, the same phenotype P (for 162 
example, an enzyme with a  specific fold and catalytic activity) is typically specified by many 163 
genotypes. I denote the set of these genotypes by GP. Second, the same genotype can also specify 164 
multiple phenotypes (Lipman and Wilbur, 1991; Schuster et al., 1994; Keefe and Szostak, 2001; 165 
Rodrigues and Wagner, 2009; Araya et al., 2012; Roscoe et al., 2013; Greenbury et al., 2014; 166 
Payne and Wagner, 2014). 167 
The genotypes encoding any one phenotype P occupy some fraction p=|GP|/|G| of genotype 168 
space. The quantity 𝐼𝐼𝑃𝑃: = −𝑙𝑙𝑙𝑙𝑙𝑙2(𝑝𝑝) = 𝑙𝑙𝑙𝑙𝑙𝑙2|𝐺𝐺| − 𝑙𝑙𝑙𝑙𝑙𝑙2|𝐺𝐺𝑃𝑃| can be viewed as the difference in 169 
Shannon entropy of two random variables that assume values 𝑙𝑙 ∈ 𝐺𝐺 with probability 1/𝐺𝐺 and 170 𝑙𝑙 ∈ 𝐺𝐺𝑃𝑃 with probabilities 1/𝐺𝐺𝑃𝑃, respectively (Cover and Thomas, 2006; Wagner, 2017). 171 
(𝑙𝑙𝑙𝑙𝑙𝑙2(𝑥𝑥) denotes the binary logarithm of x.) In various contexts, quantities analogous to 𝐼𝐼𝑃𝑃 are 172 
called self-information, functional information, surprisal, and (biological) complexity (Adami et 173 
al., 2000; Carothers et al., 2004; Cover and Thomas, 2006; Wagner, 2017). I here refer to 𝐼𝐼𝑃𝑃 as 174 
the informational complexity of the phenotype P (Adami et al., 2000; Carothers et al., 2004; 175 
Wagner, 2017). It ranges from a minimum of zero in the (extreme and trivial) case of 𝑝𝑝 = 1, i.e., 176 
every genotype encodes the phenotype, to 𝑙𝑙𝑙𝑙𝑙𝑙2(|𝐺𝐺|) if only one genotype in genotype space 177 
encodes the phenotype. The more genotypes encode a phenotype, the smaller is the informational 178 





I will here focus on pairs of phenotypes, an old (ancestral) phenotype (PO) and a new (derived) 180 
phenotype (PN) that may emerge as an exaptation from the old phenotype or originate de novo. I 181 
will denote the fraction of genotype space that is occupied by genotypes encoding these two 182 
phenotypes as pO and pN, respectively. The amount of information that is needed to specify the 183 
new phenotype de novo is given by 𝐼𝐼𝑁𝑁 =– 𝑙𝑙𝑙𝑙𝑙𝑙2 (𝑝𝑝𝑁𝑁). I want to compare this quantity to the 184 
amount of information needed if the new phenotype is to originate in an organism that already 185 
has the old phenotype. To compute the latter quantity, we can restrict ourselves to those 186 
genotypes that already encode the old phenotype PO, which occupy a fraction pO of genotype 187 
space. Among these genotypes, some fraction will also have the new phenotype, and I will 188 
denote this fraction as pON (Figure 1a). The amount of additional information required to encode 189 
phenotype PN is equivalent to the proportion of genotypes with both old and new phenotypes, 190 
among all genotypes with the old phenotype. It is given by  191 𝐼𝐼𝑒𝑒𝑒𝑒 = −𝑙𝑙𝑙𝑙𝑙𝑙2 �𝑝𝑝𝑂𝑂𝑂𝑂𝑝𝑝𝑂𝑂 �.          (1) 192 
and is related to a Kullback-Leibler distance, an elementary quantity from information theory 193 
(Cover and Thomas, 2006; Wagner, 2017). 194 
To compare the amount of information needed for a de novo and an exaptive origin of 𝑃𝑃𝑁𝑁, we 195 
can compute the difference 196 ∆𝐼𝐼𝑒𝑒𝑒𝑒 ≔ 𝐼𝐼𝑁𝑁 − 𝐼𝐼𝑒𝑒𝑒𝑒 = −𝑙𝑙𝑙𝑙𝑙𝑙2(𝑝𝑝𝑁𝑁) − [−𝑙𝑙𝑙𝑙𝑙𝑙2 �𝑝𝑝𝑂𝑂𝑂𝑂𝑝𝑝𝑂𝑂 �]= 𝑙𝑙𝑙𝑙𝑙𝑙2 � 𝑝𝑝𝑂𝑂𝑂𝑂𝑝𝑝𝑂𝑂𝑝𝑝𝑂𝑂�   (2) 197 
If this difference is positive, then more information is needed to specify the new phenotype de 198 
novo rather than starting from the old phenotype. In this sense, it is easier to evolve this 199 
phenotype from an existing phenotype. I note that 𝐼𝐼𝑁𝑁 is the maximum value that ∆𝐼𝐼𝑒𝑒𝑒𝑒 can 200 
assume, because 𝐼𝐼𝑒𝑒𝑒𝑒 ≥ 0. That is, the maximal informational benefit that an old phenotype can 201 
provide for the origin of a new phenotype can be no greater than the amount of information 202 
needed to specify the new phenotype itself de novo. One can thus normalize ∆𝐼𝐼𝑒𝑒𝑒𝑒, dividing it by 203 𝐼𝐼𝑁𝑁 to yield 204 
∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 = 1 − 𝑔𝑔𝑙𝑙𝑔𝑔2�𝑝𝑝𝑂𝑂𝑂𝑂𝑝𝑝𝑂𝑂 �𝑔𝑔𝑙𝑙𝑔𝑔2(𝑝𝑝𝑂𝑂)         (3) 205 
This quantity will assume the maximal value of ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 = 1 when it is informationally maximally 206 
advantageous to specify the new phenotype from the old phenotype, compared to specifying it de 207 





distinguished that the following examples will illustrate. I will restrict myself to 𝑝𝑝𝑂𝑂𝑁𝑁 > 0 (Figure 209 
1a), because it is the most relevant case for the exaptive origin of new phenotypes.  210 
Results   211 
Transcription factor binding sites. The experimental technology of protein binding 212 
microarrays can identify all short DNA sequences in a genotype space that a given transcription 213 
factor can bind (Badis et al., 2009; Weirauch et al., 2014). Briefly, this technology quantifies the 214 
binding of transcription factors to more than 104 different oligonucleotides of a given length 215 
immobilized on a microarray. The resulting data is already available for thousands of 216 
transcription factors (Badis et al., 2009; Newburger and Bulyk, 2009; Weirauch et al., 2014). I 217 
here analyze previously published data for the binding of 187 different mouse transcription 218 
factors to each such sequence in a genotype space of 48=65,536 DNA sequences (Badis et al., 219 
2009; Weirauch et al., 2014; Aguilar-Rodriguez et al., 2017).  220 
In the genotypes space of mouse transcription factors I study, individual transcription factors 221 
bind between 103 and 2933 sites, implying that between − log2(2933/48) = 4.48 and 222 −log2(103/48) = 9.31 bits (depending on the transcription factor) need to be specified to 223 
encode a transcription factor binding phenotype (Wagner, 2017). Among all (187×186)/2=17391 224 
possible pairs of transcription factors, these sets of binding sites overlap, i.e., 𝑝𝑝𝑂𝑂𝑁𝑁 > 0 for the 225 
vast majority (84.2%, 14645 ) of factor pairs. For these pairs, it is possible to transform one 226 
binding phenotype into another without transitioning through a site that is bound by a third factor 227 
or by no factor.  228 
Figure 2a shows histograms of ∆𝐼𝐼𝑒𝑒𝑒𝑒 and ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛(inset). The distributions are slightly platykurtic, 229 
i.e., with fewer values around the mean, and fewer very large and small values  than expected 230 
from a normal distribution (red line).  The values of ∆𝐼𝐼𝑒𝑒𝑒𝑒 range from -5.8 bits to +7.5 bits, with a 231 
slight excess of large values. Specifically, ∆𝐼𝐼𝑒𝑒𝑒𝑒 lies between +5.8 and +7.5 bits (∆𝐼𝐼𝑒𝑒𝑒𝑒 >232 −min ∆𝐼𝐼𝑒𝑒𝑒𝑒) for 70 TF pairs. Evolving a new binding specificity exaptively is especially 233 
advantageous for these TF pairs.  234 
It is useful to distinguish three cases according to the sign of ∆𝐼𝐼𝑒𝑒𝑒𝑒, beginning with ∆𝐼𝐼𝑒𝑒𝑒𝑒 > 0. 235 
Consider the transformation of binding sites for SOX1, a transcription factor important in 236 
neurogenesis, into that for the related factor SRY (sex-determining region Y), which plays a role 237 
in gonad development (Guth and Wegner, 2008). For these DNA binding phenotypes, ∆𝐼𝐼𝑒𝑒𝑒𝑒 =238 
4.62 (∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 = 0.79). This means that evolving a binding site for SRY from one for SOX1 239 
requires 4.62 fewer bits – more than the information encoded in two base pairs – than evolving it 240 





Specifically, 42 percent (701) of the 1670 of binding sites of SOX1 are also binding sites for 242 
SRY. 243 
SRY and SOX1 are from the same gene family (Guth and Wegner, 2008), and their high value of 244 ∆𝐼𝐼𝑒𝑒𝑒𝑒 is not a coincidence: Sets of binding sites overlap to the greatest extent for transcription 245 
factor pairs that originated through gene duplication (Weirauch et al., 2014). Some of the highest 246 
values of ∆𝐼𝐼𝑒𝑒𝑒𝑒 come from such pairs. Among them are the genes encoding the odd-skipped-247 
related transcription factors OSR1 and OSR2, which are involved in kidney, heart and palate 248 
development, and are duplicates with 65% amino acid sequence identity (Zhang et al., 2011). 249 
Evolving binding specificity for OSR2 from a binding site of OSR1 has ∆𝐼𝐼𝑒𝑒𝑒𝑒=6.45, i.e., it 250 
requires 6.45 fewer bits than evolving such specificity de novo. This value is not much lower 251 
than the information content of 𝐼𝐼𝑁𝑁=7.45 for an OSR1 binding site itself (∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 = 0.89), 252 
indicating that most of the information encoding an OSR2-binding phenotype is already encoded 253 
in an OSR1-binding phenotype.   254 
A second case is ∆𝐼𝐼𝑒𝑒𝑒𝑒  < 0, which means that it requires less information to evolve the new 255 
binding specificity de novo than from the old binding specificity. This will be the case if few 256 
DNA molecules can bind both transcription factors, such that 𝑝𝑝𝑂𝑂𝑁𝑁 is very small compared to 𝑝𝑝𝑂𝑂 257 
and 𝑝𝑝𝑁𝑁, which means that the amount of additional information 𝐼𝐼𝑒𝑒𝑒𝑒 to specify the new phenotype 258 
is very large.  259 
One example involves the cell cycle regulators E2F3 and ARID3A (AT-rich interactive domain-260 
containing protein 3A), members of a transcription factor family involved in hematopoiesis 261 
(Lees et al., 1993). ∆𝐼𝐼𝑒𝑒𝑒𝑒 = −5.4 bits for the evolution of E2F3 from ARID3A binding sites, 262 
whereas it takes only 𝐼𝐼𝑁𝑁=4.8 bits to specify a binding site for E2F3 de novo. It follows that 𝐼𝐼𝑒𝑒𝑒𝑒 =263 
10.2 bits, and that  ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛=-1.13, that is, it costs 113 percent more to evolve E2F3 binding from 264 
ARID3A binding than to evolve it de novo. The reason is that only two of the 2372 E2F3 binding 265 
sites are also binding sites for ARID3A (𝐼𝐼𝑒𝑒𝑒𝑒 = − log(2/2372) = 10.21). Starting from an 266 
ARID3A binding phenotype, much additional information is needed to evolve a binding site for 267 
E2F3.  268 
More generally, as the fraction 𝑝𝑝𝑂𝑂𝑁𝑁  of genotypes that encode both phenotypes declines (and 269 
thus, as −𝑙𝑙𝑙𝑙𝑙𝑙2 𝑝𝑝𝑂𝑂𝑁𝑁 increases), ∆𝐼𝐼𝑒𝑒𝑒𝑒 also declines (Figure 2b). The two quantities are highly 270 
correlated (Spearman’s rs between −𝑙𝑙𝑙𝑙𝑙𝑙2 𝑝𝑝𝑂𝑂𝑁𝑁 and ∆𝐼𝐼𝑒𝑒𝑒𝑒: rs = - 0.85, p<10-17, n=14645)  271 
In a third scenario, ∆𝐼𝐼𝑒𝑒𝑒𝑒 ≈ 0. That is, it is about equally likely that a binding site evolves de novo 272 





factors is equal to that expected by chance, i.e., if binding sites for the two transcription factors 275 
were independently distributed in genotype space. Examples where ∆𝐼𝐼𝑒𝑒𝑒𝑒 ≈ 0 include ZIC1 (Zinc 276 
finger of the cerebellum) and SMAD3 (Mothers against decapentaplegic homolog 3), a regulator 277 
of cell proliferation (Zhang et al., 1996; Ali et al., 2012). Here, ∆𝐼𝐼𝑒𝑒𝑒𝑒 = −0.0046 bits, such that 278 
starting from a SMAD3 binding phenotype entails neither a strong advantage or disadvantage in 279 
evolving a binding site for ZIC1. Overall, 178 (0.01%) pairs of transcription factors have 280 
|∆𝐼𝐼𝑒𝑒𝑒𝑒| < 0.05, and figure 2a shows that the percentage of such transcription factors is smaller 281 
than expected if ∆𝐼𝐼𝑒𝑒𝑒𝑒 followed a normal or binomial distribution.  282 
Metabolic phenotypes. Metabolism is a complex network of enzyme-catalyzed chemical 283 
reactions that transforms environmental nutrients into small biomass molecules, such as amino 284 
acids and nucleotides. A metabolic genotype is that part of a genome’s DNA that encodes all 285 
metabolic enzymes. Instead of representing such genotypes directly as DNA, metabolic systems 286 
analysis often represents them in a more abstract, reaction-centered way, as the complement of 287 
biochemical reactions that an organism’s metabolism can catalyze (Edwards and Palsson, 2000; 288 
Schellenberger et al., 2010). This reaction-centered representation is especially appropriate 289 
wherever the elementary events of genetic change affect not just single nucleotides, but the 290 
presence or absence of enzyme-coding genes, such as in horizontal gene transfer and DNA 291 
recombination. Because the metabolic reactions encoded by any one genotype are a subset of a 292 
much larger “universe” of biochemical reactions, one can represent any organism’s metabolic 293 
genotype as a binary vector whose entries indicates the presence (‘1’) or absence (‘0’) of specific 294 
metabolic reactions (Figure 3a). For tractability, I here analyze the metabolic genotype space of 295 
central metabolism, whose 245 members encode metabolic networks that are formed by all 296 
possible subsets of 45 chemical reactions that can vary without necessarily abolishing an 297 
organism’s viability in some environment (Hosseini et al., 2015). I note that the reaction 298 
complement of central carbon metabolisms also varies among organisms in the wild (Danson, 299 
1989; Romano and Conway, 1996; Huynen et al., 1999). If |𝐺𝐺𝑃𝑃| denotes the total number of 300 
genotypes (subsets of chemical reactions) that convey viability in a given environment, then 301 −𝑙𝑙𝑙𝑙𝑙𝑙2(|𝐺𝐺𝑃𝑃|/245) quantifies the informational complexity of this viability phenotype. If a 302 
specific set of chemical reactions convey viability, then any superset of this set will do so as well 303 
(Hosseini et al., 2015). 304 
Earlier work has used the experimentally validated computational method of flux balance 305 
analysis (FBA) to predict metabolic phenotypes for all 245central carbon genotypes (Hosseini et 306 
al., 2015). These phenotypes are viability phenotypes. That is, they reflect a metabolism’s ability 307 
to produce biomass precursors essential for viability from a single source of carbon and energy, 308 





viability on acetate (ace), 𝛼𝛼-ketoglutarate (akg), fumarate (fum), fructose (fru), glucose (glc), 310 
glutamate (glu), lactate (lac), malate (mal), pyruvate (pyr), and succinate (suc). A new phenotype 311 
conveys viability on a new carbon source, and can come about through genetic changes, such as 312 
the addition of new enzyme-coding genes to a genome as a result of horizontal gene transfer and 313 
recombination (Hosseini et al., 2016).  314 
Between 𝐼𝐼𝑔𝑔𝑔𝑔𝑔𝑔=14.47 bits (glucose) and 𝐼𝐼𝑎𝑎𝑔𝑔𝑒𝑒=21.6 bits (acetate), or, equivalently, metabolic 315 
reactions, are necessary to ensure viability on any one of the 10 carbon sources I consider. Figure 316 
3c shows the distributions of ∆𝐼𝐼𝑒𝑒𝑒𝑒 and ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 (inset). One noteworthy difference to the 317 
transcription factor binding phenotypes I considered above is that both quantities are always 318 
greater than zero, regardless of which pair of old and new phenotypes one considers. This means 319 
that it always requires more information to specify a new metabolic phenotype de novo than 320 
starting from an old phenotype. However, ∆𝐼𝐼𝑒𝑒𝑒𝑒 still varies broadly, from 9.83 to 16.9 bits. The 321 
minimal value of ∆𝐼𝐼𝑒𝑒𝑒𝑒 =9.83 bits (𝐼𝐼𝑒𝑒𝑒𝑒=4.64 bits) holds for the transition from metabolisms viable 322 
on 𝛼𝛼-ketoglutarate to metabolisms viable on glucose. It means that if a metabolism is already 323 
viable on 𝛼𝛼-ketoglutarate, one needs to specify on average 9.83 fewer bits to render it viable on 324 
glucose than when specifying a metabolism viable on glucose de novo. For this example, 325 ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛=0.68. That is, viability on 𝛼𝛼-ketoglutarate  already provides 68% of the necessary 326 
information to specify viability on glucose. At the other extreme is the value of ∆𝐼𝐼𝑒𝑒𝑒𝑒=16.9 327 
(𝐼𝐼𝑒𝑒𝑒𝑒=0.39) bits, which are necessary for a metabolism viable on succinate to originate from one 328 
viable on acetate instead of de novo. The corresponding value of ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛=0.98 shows that it is 329 
close to maximally advantageous if the new phenotype originates exaptively rather than de novo. 330 
When different new phenotypes are created from the same old phenotype, ∆𝐼𝐼𝑒𝑒𝑒𝑒 can also vary 331 
among these phenotypes. For example, starting out from viability on fructose, the informational 332 
advantage of creating any one of the other nine phenotypes exaptively ranges between ∆𝐼𝐼𝑒𝑒𝑒𝑒=9.9 333 
bits (𝛼𝛼-ketoglutarate, ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛=0.65) and 14.47 bits (glucose, ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛=1). Similarly, the amount of 334 
additional information 𝐼𝐼𝑒𝑒𝑒𝑒 one needs to specify to obtain a new phenotype is low for some new 335 
phenotypes (malate from fructose: 𝐼𝐼𝑒𝑒𝑒𝑒=3.1 bits) and much higher for others (acetate from 336 
fructose: 𝐼𝐼𝑒𝑒𝑒𝑒=8.7 bits). Not surprisingly, the informationally expensive new phenotypes tend to 337 
be those that require many biochemical reactions, i.e., the phenotypes that are informationally 338 
complex (Spearman’s rs=0.42 between 𝐼𝐼𝑁𝑁 and 𝐼𝐼𝑒𝑒𝑒𝑒, and Spearman’s rs=0.53 between 𝐼𝐼𝑁𝑁 and ∆𝐼𝐼𝑒𝑒𝑒𝑒;  339 
p<3.6×10-5; n=90).  340 
Not just the new phenotype, but also the old, original phenotype can influence the informational 341 
advantage ∆𝐼𝐼𝑒𝑒𝑒𝑒 of exaptation and the amount of information that needs to be specified for the 342 





nine novel phenotypes starting from each of the 10 old phenotypes I consider. The informational 344 
advantage of exaptation clearly is greater for some starting phenotypes (e.g., acetate) than for 345 
others (glucose). The greater the informational complexity 𝐼𝐼𝑂𝑂 of the starting phenotype, the 346 
smaller the number of additional bits (reactions) that need to be specified, and the greater the 347 
informational advantage of exaptation over de novo evolution of the new phenotype. 348 
(Spearman’s rs= -0.57 between 𝐼𝐼𝑂𝑂 and 𝐼𝐼𝑒𝑒𝑒𝑒, and Spearman’s rs=0.53 between 𝐼𝐼𝑂𝑂and ∆𝐼𝐼𝑒𝑒𝑒𝑒;  349 
p<8×10-8; n=90).  350 
Discussion 351 
My analysis of new phenotype origins is centered on transitions between phenotypes and not 352 
genotypes, because most phenotypes are encoded by multiple genotypes. Differences in the 353 
genetic information needed to encode a new and an old phenotype are well-suited to understand 354 
the likelihood of transitions between specific phenotypes, because they correlate with the amount 355 
of genetic change such transitions would require.  356 
I considered two very different classes of phenotypes whose potential to originate exaptively 357 
differs. The first is the ability of DNA to bind a specific transcription factor, brought forth by 358 
specific sequences of nucleotides on a linear DNA string. The second is a metabolism’s ability to 359 
synthesize essential molecules in a specific environment. It is brought forth by a chemical 360 
reaction network. A de novo origin is informationally cheaper than an exaptive origin for many 361 
transcription factor binding phenotypes.  This does not hold for metabolic phenotypes, where an 362 
exaptive origin is always cheaper.  363 
The cheaper exaptive origin of metabolic phenotypes has two reasons. The first is that metabolic 364 
phenotypes are more complex, even in the simple systems I study, requiring up to 21 bits 365 
compared to the maximally 9 bits of transcription factor binding. Second, and more importantly, 366 
the two traits have very different architectures. Metabolism can be partitioned into two parts. The 367 
first is a conserved core which comprises chemical reactions (enzymes) and pathways that are 368 
shared by many organisms, and that are needed for fundamental processes such as biosyntheses 369 
and energy conversion. The second is a more variable periphery, which comprises reactions and 370 
pathways responsible for viability in specific environments.  Viability in new environments is 371 
primarily caused by alterations to this periphery (Pal et al., 2005; Bilgin and Wagner, 2012). 372 
What is more, as little as one or two reactions in the periphery usually suffice to bring forth 373 
viability in a new environment (Bilgin and Wagner, 2012). In other words, novel metabolic 374 
phenotypes result from the co-option of a metabolic core for a new role through the addition of 375 
novel metabolic reactions. This core-periphery structure has no counterpart in transcription factor 376 





In the transcription factor binding phenotypes I study, two bits correspond to one completely 378 
specified nucleotide. In the more abstract, reaction-based representation I use for metabolic 379 
phenotypes, one bit corresponds to one biochemical reaction. The two representations are not 380 
directly comparable. In a DNA-based representation of metabolic genotypes, every metabolic 381 
reaction would require a stretch of DNA that encodes the necessary enzyme, and thus requires 382 
much more than one bit of information. (Although the information content of some protein-based 383 
phenotypes, such ATP-binding, has been estimated (Keefe and Szostak, 2001; Carothers et al., 384 
2004), this information content is unknown for most enzymes.) However when recombination or 385 
horizontal gene transfer are equally or more important than point mutations in creating novel 386 
phenotypes, a reaction-centered representation of information may be appropriate. This is indeed 387 
frequently the case, and especially in bacteria, where novel metabolic phenotypes often arise 388 
through horizontal transfer of enzyme-coding genes into a bacterial genome (Ochman et al., 389 
2000; Pal et al., 2005; Copley, 2009). Importantly, a change in metabolic genotype 390 
representation would not affect the central conclusions of my analysis. For example, it would not 391 
change the fact that few reaction changes are needed to create new metabolic phenotypes. It 392 
would also not change the generally exaptive origin of novel metabolic phenotypes, nor would it 393 
change the observation that some phenotypes are informationally more expensive to create than 394 
others.  395 
In the model of central carbon metabolism I consider, all central carbon metabolisms viable on 396 
fructose are also viable on glucose (Supplementary Results). Thus, viability on glucose is 397 
informationally ‘free’ – it requires no additional information (𝐼𝐼𝑒𝑒𝑒𝑒 = 0), because it is an 398 
inevitable, latent by-product of viability on fructose. Not all latent traits are inevitable, because 399 
for many of the phenotypes I consider, only some – but not all – genotypes encode both an old 400 
(adaptive) and a new phenotype, that is, they lie in the intersection of the sets of genotypes 401 
encoding each trait (Figure 1a). In an organism with such a genotype the new phenotype may be 402 
latent. One can quantify the likelihood that an organism with an existing phenotype PO also 403 
harbors a “new” and possibly latent phenotype PN as 𝑝𝑝𝑂𝑂𝑁𝑁/𝑝𝑝𝑂𝑂, i.e., as the fraction of genotypes 404 
encoding O that also encode N.  405 
Latent traits of both kinds – inevitable or not – are especially frequent in metabolism 406 
(Khersonsky and Tawfik, 2010; Nam et al., 2012; Barve and Wagner, 2013). They result both 407 
from the promiscuous activity of enzymes (Khersonsky and Tawfik, 2010; Nam et al., 2012), and 408 
from linear pathways of chemical reactions in parts of metabolism, where the ability to use one 409 
nutrient entails the ability to use others downstream of it (Barve and Wagner, 2013; Hosseini and 410 
Wagner, 2016). Latent phenotypes can also occur in the transcription factor binding phenotypes I 411 





0 (Figure 1a), and where regulatory cross-talk between two transcription factors can thus take 413 
place. For both metabolic and regulatory traits, the potential for a phenotype PO to harbor a latent 414 
phenotype PN varies widely.  415 
The information theoretic framework I use creates concrete predictions. One of them is that 416 
phenotypes where ∆𝐼𝐼𝑒𝑒𝑒𝑒<0 should more often originate de novo than by co-option from an 417 
existing phenotype PO. This prediction is in principle testable, by analyzing the evolutionary 418 
origins of novel transcription factor binding sites through comparative genomics. A second 419 
prediction regards the observation that many novel traits – from aerobic respiration and nitrogen 420 
fixation to eye lenses and dissected leaves – have originated multiple times in evolution 421 
(Vermeij, 2006). All else being equal, I predict that phenotypes with low information content, or 422 
with little required additional information when they evolve exaptively, will have originated 423 
more often in life’s evolution than informationally more complex phenotypes. A third prediction 424 
is that de novo origins should become progressively rarer as phenotypes become more complex, 425 
because it is informationally so much cheaper to evolve them as exaptations from existing 426 
phenotypes.  427 
One limitation of my analysis is that I do not consider how easily a series of DNA mutations can 428 
access the set of genotypes encoding a new phenotype PN from genotypes encoding and old 429 
phenotype PO. Both sets of genotypes might be highly fragmented in genotype space, and only 430 
some of the subsets encoding phenotype PO  may intersect with a set of genotypes encoding PN. 431 
If so, exaptive evolution of a new phenotype may be unlikely. For the transcription factor 432 
binding phenotypes and the metabolic phenotypes I consider here, this is not the case, because 433 
such fragmentation is very limited or nonexistent (Hosseini et al., 2015; Aguilar-Rodriguez et al., 434 
2017). Fragmentation may exist for other traits, but a mix of computational analysis and 435 
experimental data shows for systems as different as evolving proteins and RNA molecules, 436 
regulatory circuits, and genome scale metabolisms, that genotypes encoding the same phenotype 437 
do not usually form highly fragmented sets but are instead connected in large networks that reach 438 
far through genotype space (Schuster et al., 1994; Schultes and Bartel, 2000; Ciliberti et al., 439 
2007; Hayden et al., 2011; Greenbury et al., 2014; Payne and Wagner, 2014). Where 440 
fragmentation exists, it can sometimes be overcome through a combination of genetic drift, high 441 
mutation rates, or large population sizes (Weinreich and Chao, 2005; Weissman et al., 2009).  442 
A second limitation is the tacit assumption that all genotypes encoding a phenotype are 443 
equivalent, but in practice they are not. For example, the metabolic enzymes encoded by 444 
different variants of the same gene may differ in their catalytic rate or thermodynamic stability, 445 





quantitative fitness data on large enough numbers of genotypes to incorporate such data into any 447 
of the examples I discuss. However, when such data become available, the theoretical framework 448 
I propose will be able to accommodate it. For example, one can weight different genotypes in 449 
calculations of informational complexity according to their likelihood of occurrence in a 450 
population, which may depend on their fitness.  451 
A third limitation is that I have focused on systems where genotype space is sufficiently small to 452 
be enumerated exhaustively. For informationally more complex phenotypes this is not going to 453 
be possible. It is tempting to overcome this limitation through the simplifying assumption that 454 
individual system parts – here, nucleotides or biochemical reactions – contribute additively to a 455 
phenotype (Adami et al., 2000). However, doing so can lead to substantial underestimates of 456 
phenotypic information content (Wagner, 2017). An alternative is to sample sequence space in 457 
ways suitable to infer phenotypic complexity. However, statistical methods to do so are still in 458 
their infancy (Wagner, 2017). Our dramatically increasing ability to genotype and phenotype 459 
large populations of organisms will hopefully prompt the development of such methods. 460 
Whether they will ever allow us to apply information theory to phenotypes as complex as our 461 
middle ear bones is an open question. But information theory can undoubtedly help us turn the 462 
analysis of trait origins into a quantitative science suitable to study phenotypes of ever-increasing 463 
complexity. 464 
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Figure Captions 473 
 474 
Figure 1. Various possible relationships among sets of genotypes with the same phenotype. 475 
Large squares symbolize genotype space, circles correspond to sets of genotypes with the same 476 
phenotype, which can be either an old phenotype 𝑃𝑃𝑂𝑂 (set O), or a new phenotype 𝑃𝑃𝑁𝑁 (set N). a) 477 
The two genotype sets have a non-empty intersection (denoted by 𝑂𝑂 ∩ 𝑁𝑁), which is the main 478 
scenario I consider. b) The two genotype sets have an empty intersection (𝑝𝑝𝑂𝑂𝑁𝑁=0), which makes 479 
exaptation unlikely or impossible. c) The set of genotype with the old phenotype 𝑃𝑃𝑂𝑂 is a subset 480 
of that with the new phenotype 𝑃𝑃𝑁𝑁. In this case, the new phenotype is an inevitable, possibly 481 
latent by-product of the old phenotype. 482 
Figure 2: The informational cost of exaptation in transcription factor binding phenotypes. 483 
a) Histogram of ∆𝐼𝐼𝑒𝑒𝑒𝑒 (in bits) and ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 (inset) for 14645 pairs of transcription factors where 484 𝑝𝑝𝑂𝑂𝑁𝑁>0. The red line shows a Gaussian distribution. b) ∆𝐼𝐼𝑒𝑒𝑒𝑒 (in bits) as a function of the negative 485 
binary logarithm of 𝑝𝑝𝑂𝑂𝑁𝑁, the fraction of genotypes (transcription factor binding sites) that can 486 
bind both factors in a pair. The black line is a linear regression line.  487 
Figure 3. Metabolic exaptations. a) The genotype encoding a network of metabolic reactions 488 
can be represented through the presence (black type, ‘1’) or absence (grey type, 0’) of individual 489 
metabolic reactions, which are represented in this hypothetical example through their 490 
stoichiometric equations. In this analysis I consider 45 reactions from central carbon metabolism 491 
whose presence can vary and still allow viability.  b) The environments I consider here are 492 
chemically minimal environments (Hosseini et al., 2015) that differ only in one of the 10 carbon 493 
sources shown here. A carbon source is shown as supporting viability (black type, ‘1’) if a 494 
metabolism can synthesize each of 12 different biomass precursors (Figure S1) when this carbon 495 
source is the only carbon source. c) Distribution of ∆𝐼𝐼𝑒𝑒𝑒𝑒 (in bits) and the normalized ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 496 
(inset) for the 90 pairs of carbon sources that can be formed by the 10 carbon sources I consider 497 
here. d) Mean (circles) and standard error of the mean (whiskers) for ∆𝐼𝐼𝑒𝑒𝑒𝑒 (in bits) and 𝐼𝐼𝑒𝑒𝑒𝑒 (inset) 498 
for the nine novel phenotypes that can be formed from each of the 10 old phenotypes shown on 499 
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1  Glucose + ATP → Glucose 6-phosphate + ADP
1  Fructose 1,6-bisphosphate → Fructose 6-phosphate + Pi
0  Isocitrate → Glyoxylate + Succinate
1  Acetoacetyl-Co + Gyoxylate → CoA + Malate
1  Oxaloacetate + ATP → Phosphoenolpyruvate + CO2 +ADP
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Latent phenotypes are inevitable by-products of other phenotypes that do not require 
additional genetic information to be specified. There are two pairs of carbon sources where ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛 assumes its maximally possible value of one. These are fructose-glucose, as well as 
fumarate-malate.  For the first pair, it is noteworthy that the amount of information needed to 
specify each phenotype is very similar (𝐼𝐼𝑓𝑓𝑓𝑓𝑓𝑓=14.54 bits, and 𝐼𝐼𝑔𝑔𝑔𝑔𝑔𝑔=14.47 bits). More importantly, 
closer inspection reveals that all 1.47×109 genotypes that are viable on fructose are also viable on 
glucose (1.55×109 genotypes, Figure 1c). In other words, if a metabolism is viable on fructose 
already, it takes no additional information to turn it into a metabolism viable on glucose. 
Viability on glucose is an inevitable, latent by-product of viability on fructose, because glucose 
and fructose are biochemically similar and metabolized by similar pathways. It is not surprising 
then that ∆𝐼𝐼𝑒𝑒𝑒𝑒 =14.47 bits, exactly the same amount of information needed to specify viability on 
glucose de novo. This explains the maximal possible value of ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛=1. I note that the converse 
does not hold, that is, turning a metabolism that is viable on glucose into one that is viable on 
fructose requires additional information, because not all metabolisms viable on glucose are also 
viable on fructose. However, this additional information is quite small (𝐼𝐼𝑒𝑒𝑒𝑒=0.07 bits), because 
the vast majority of metabolisms viable on glucose (94.8%) are already viable on fructose. More 
specifically, ∆𝐼𝐼𝑒𝑒𝑒𝑒=14.47 bits, which is slightly lower than the possible maximum of 𝐼𝐼𝑁𝑁=14.54 for 
fructose, yielding ∆𝐼𝐼𝑒𝑒𝑒𝑒,𝑛𝑛=0.995. The same qualitative patterns exist for fumarate and malate, i.e., 
all metabolisms viable on fumarate are also viable on malate. In sum, even simple metabolic 













Figure S1: Central carbon metabolism. Figure and captions with modification from (Hosseini 
et al., 2015). Each arrow corresponds to one of the internal reactions considered here and in 
(Hosseini et al., 2015). Metabolites are indicated by acronyms (Hosseini et al., 2015). Boxed 
metabolites correspond to the 13 essential biomass precursors D-glucose-6-phosphate (g6p), D-
fructose 6-phosphate (f6p), glyceraldehyde 3-phosphate (g3p), 3-phospho-D-glycerate (3pg), 
phosphoenolpyruvate (pep), pyruvate (pyr), acetyl CoA (accoa), D-eryhtrose 4-phosphate (e4p), 
D-ribose 5-phosphate (r5p), L-glutamine (gln-L), L-glutamate (glu-L), oxaloacetate (oaa), and 2-
oxoglutarate (α-ketoglutarate, akg). Note that four of the precursors (accoa, g3p, f6p and e4p) are 
shown more than once for visual clarity. Six of the 51 arrows (reactions) shown here cannot be 
eliminated without abolishing viability in each of the environments considered here (Hosseini et 
al., 2015). Because such reactions are always essential I excluded them from all calculations.  
